Loading…

Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy

•The impact of adverse pathologic pT3a features on small renal masses is unclear.•We compared clinical outcomes of pT3a vs pT1 small renal masses at our institution.•9.04% of resected malignant small renal masses were deemed pT3a post-operatively.•Small pT3a masses had worse recurrence-free and canc...

Full description

Saved in:
Bibliographic Details
Published in:Urologic oncology 2023-09, Vol.41 (9), p.391.e5-391.e11
Main Authors: Khaleel, Sari, Truong, Hong, Jiang, Song, K-Lee, Paul, Davelman, Benjamin, Gordon, Danielle, Benfante, Nicole, Arora, Arshi, Ostrovnaya, Irina, Tickoo, Satish, Coleman, Jonathan, Hakimi, A. Ari, Russo, Paul
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The impact of adverse pathologic pT3a features on small renal masses is unclear.•We compared clinical outcomes of pT3a vs pT1 small renal masses at our institution.•9.04% of resected malignant small renal masses were deemed pT3a post-operatively.•Small pT3a masses had worse recurrence-free and cancer-specific survival.•pT3a stage portends worse clinical outcomes even for small renal masses. While most small renal masses (SRM) < 4 cm have an excellent prognosis following resection, the impact of adverse T3a pathologic features on oncologic outcomes of SRMs remains unclear. We sought to compare clinical outcomes for surgically resected pT3a versus pT1a SRMs at our institution. We retrospectively reviewed records of patients who underwent radical or partial nephrectomy (RN, PN) for renal tumors
ISSN:1078-1439
1873-2496
1873-2496
DOI:10.1016/j.urolonc.2023.06.010